Brand Engagement Network (NASDAQ: BNAI) lands $250K AI pharma project with recurring fees

Rhea-AI Filing Summary

Brand Engagement Network, Inc. disclosed that it entered into a Vendor Services Project Agreement on December 19, 2025 with a leading global advertising and communications agency, which is part of one of the world’s largest advertising holding companies. The project covers development of a custom AI engagement communication solution supporting a prescription pharmaceutical product for a top-10 global pharmaceutical client of the agency.

The company expects to recognize $250,000 in revenue in the fourth quarter of 2025 from development services under two Statements of Work, subject to performance and acceptance. It also anticipates beginning monthly recurring license fees in the first quarter of 2026 once the AI solution is fully implemented and deployed.

Insights

Technology and commercial strategy analyst

BNAI discloses a $250,000 AI project with potential recurring fees.

Brand Engagement Network has signed a Vendor Services Project Agreement to build a custom AI engagement communication solution for a prescription pharmaceutical product, working through a leading global advertising agency for a top-10 global pharmaceutical client. The agreement ties near-term revenue to development work under two Statements of Work.

The company expects to record $250,000 of revenue in Q4 2025, contingent on performance and acceptance, which frames this as a contracted but delivery-dependent contribution. In addition, monthly recurring license fees are anticipated to start in Q1 2026, conditioned on final implementation and deployment, introducing a potential ongoing revenue stream once the solution is live.

Overall, this development illustrates commercial adoption of BNAI’s AI engagement technology in a regulated healthcare setting, with immediate project revenue and a pathway to subscription-like license income. Actual financial contribution will depend on successful completion of deliverables in Q4 2025 and timing of deployment that enables license billing in Q1 2026.

false 0001838163 0001838163 2025-12-19 2025-12-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 19, 2025

Brand Engagement Network, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-40130		98-1574798
(State or other jurisdiction of incorporation)		Commission File Number:		IRS Employer Identification No.:

300 Delaware Ave

Suite 210

Wilmington, DE 19801

[Registrant Address]

307-757-3650

[Registrant Telephone Number]

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		BNAI		Nasdaq

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

On December 19, 2025, Brand Engagement Network, Inc. (the “Company” or “BEN”) entered into a Vendor Services Project Agreement with a leading global advertising and communications agency, a unit of one of the world’s largest advertising holding companies, pursuant to a purchase order received on December 19, 2025. The Agreement provides for the development of a custom AI engagement communication solution supporting an established prescription pharmaceutical product for a top-10 global pharmaceutical client of the Agency. The identities of the Agency and pharmaceutical company remain confidential pending formal release of the AI solution.

Under the Agreement, the Company expects to recognize $250,000 in revenue during the fourth quarter of 2025, subject to performance and acceptance, for development services provided under two Statements of Work. Monthly recurring license fees, separate from the development services, are anticipated to commence in the first quarter of 2026, subject to final implementation and deployment.

Item 9.01. Financial Statements and Exhibits.

Exhibit 99.1	Press Release dated December 29, 2025
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Brand Engagement Network, Inc.
Date: December 29, 2025	By:	/s/ Tyler Luck
	Name:	Tyler Luck
	Title:	Acting Chief Executive Officer

FAQ

What agreement did Brand Engagement Network (BNAI) enter into on December 19, 2025?

On December 19, 2025, Brand Engagement Network, Inc. entered into a Vendor Services Project Agreement with a leading global advertising and communications agency, which is part of one of the world’s largest advertising holding companies.

What is the scope of the new AI project disclosed by Brand Engagement Network (BNAI)?

The agreement covers development of a custom AI engagement communication solution supporting an established prescription pharmaceutical product for a top-10 global pharmaceutical client of the advertising agency.

How much revenue does Brand Engagement Network (BNAI) expect from this agreement in Q4 2025?

The company expects to recognize $250,000 of revenue in the fourth quarter of 2025, subject to performance and acceptance of development services provided under two Statements of Work.

When does Brand Engagement Network (BNAI) anticipate recurring license fees will begin for this AI solution?

Monthly recurring license fees, separate from the development services, are anticipated to commence in the first quarter of 2026, subject to final implementation and deployment of the AI solution.

Who are the end clients involved in Brand Engagement Network’s new AI engagement agreement?

The counterparties include a leading global advertising and communications agency and its top-10 global pharmaceutical client. Their specific identities remain confidential pending formal release of the AI solution.

What additional materials accompany Brand Engagement Network’s 8-K about this agreement?

The filing lists Exhibit 99.1, a press release dated December 29, 2025, and Exhibit 104, a cover page interactive data file embedded within the Inline XBRL document.